RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma

Previous work identified RMEL3 as a lncRNA with enriched expression in melanoma. Analysis of The Cancer Genome Atlas (TCGA) data confirmed RMEL3 enriched expression in melanoma and demonstrated its association with the presence of BRAFV600E. RMEL3 siRNA-mediated silencing markedly reduced (95%) colony formation in different BRAFV600E melanoma cell lines. Multiple genes of the MAPK and PI3K pathways found to be correlated with RMEL3 in TCGA samples were experimentally confirmed. RMEL3 knockdown led to downregulation of activators or effectors of these pathways, including FGF2, FGF3, DUSP6, ITGB3 and GNG2. RMEL3 knockdown induces gain of protein levels of tumor suppressor PTEN and the G1/S cyclin-Cdk inhibitors p21 and p27, as well as a decrease of pAKT (T308), BRAF, pRB (S807, S811) and cyclin B1. Consistently, knockdown resulted in an accumulation of cells in G1 phase and subG0/G1 in an asynchronously growing population. Thus, TCGA data and functional experiments demonstrate that RMEL3 is required for MAPK and PI3K signaling, and its knockdown decrease BRAFV600E melanoma cell survival and proliferation.

[1]  Steven J. M. Jones,et al.  Genomic Classification of Cutaneous Melanoma , 2015, Cell.

[2]  V. Sondak,et al.  Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells , 2015, Oncogene.

[3]  M. Dinger,et al.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma. , 2014, Archives of biochemistry and biophysics.

[4]  Brian Craft,et al.  The Cancer Genomics Hub (CGHub): overcoming cancer through the power of torrential data , 2014, Database J. Biol. Databases Curation.

[5]  R. Moon,et al.  WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors. , 2014, The Journal of clinical investigation.

[6]  Guo Chen,et al.  Targeted therapy resistance mechanisms and therapeutic implications in melanoma. , 2014, Hematology/oncology clinics of North America.

[7]  G. Mutlu,et al.  PAI-1–regulated extracellular proteolysis governs senescence and survival in Klotho mice , 2014, Proceedings of the National Academy of Sciences.

[8]  Jason Li,et al.  Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. , 2014, Cancer discovery.

[9]  Wei Zhao,et al.  The Functional Characterization of Long Noncoding RNA SPRY4-IT1 in Human Melanoma Cells , 2014, Oncotarget.

[10]  F. Luft,et al.  Long non-coding RNA in health and disease , 2014, Journal of Molecular Medicine.

[11]  A. Goldstein,et al.  The genetics of melanoma: recent advances. , 2013, Annual review of genomics and human genetics.

[12]  B. Su,et al.  Long Noncoding RNA HOTAIR Is Associated with Motility, Invasion, and Metastatic Potential of Metastatic Melanoma , 2013, BioMed research international.

[13]  Jason B. Lee,et al.  Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3. , 2013, The Journal of clinical investigation.

[14]  A. Yoshida,et al.  CSN5 specifically interacts with CDK2 and controls senescence in a cytoplasmic cyclin E-mediated manner , 2013, Scientific Reports.

[15]  A. Giobbie-Hurder,et al.  The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition , 2012, Clinical Cancer Research.

[16]  M. Birtwistle,et al.  Novel Somatic Mutations to PI3K Pathway Genes in Metastatic Melanoma , 2012, PloS one.

[17]  Günter P. Wagner,et al.  Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples , 2012, Theory in Biosciences.

[18]  E. Lam,et al.  Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb. , 2012, Biochimica et biophysica acta.

[19]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[20]  Walter Kolch,et al.  Biology using engineering tools: The negative feedback amplifier , 2022 .

[21]  J. Mattick,et al.  Ferritin: nanotechnology at the service of the new biomedicine , 2011 .

[22]  Muffy Calder,et al.  The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier , 2010, Science Signaling.

[23]  C. Carlotti,et al.  Novel Primate-Specific Genes, RMEL 1, 2 and 3, with Highly Restricted Expression in Melanoma, Assessed by New Data Mining Tool , 2010, PloS one.

[24]  J. Jeon,et al.  Transglutaminase 2 inhibits apoptosis induced by calciumoverload through down-regulation of Bax , 2010, Experimental & Molecular Medicine.

[25]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[26]  Azad Bonni,et al.  p38 MAP Kinase Mediates Apoptosis through Phosphorylation of BimEL at Ser-65* , 2006, Journal of Biological Chemistry.

[27]  N. Hayward.  Genetics of melanoma predisposition , 2003, Oncogene.

[28]  J. Blenis,et al.  Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.

[29]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[30]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[31]  J. Downward,et al.  Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. , 2003, Molecular cell.

[32]  Minoru Kanehisa,et al.  The KEGG database. , 2002, Novartis Foundation symposium.